2020
DOI: 10.4028/www.scientific.net/msf.988.95
|View full text |Cite
|
Sign up to set email alerts
|

Biosurfactant Screening of <i>Halomonas meridiana</i> BK-AB4 for Microbial Enhanced Oil Recovery

Abstract: Biosurfactant is produced by a certain microorganism to reduce surface tension. Microbial enhanced oil recovery (MEOR) is one of the many applications of biosurfactant. However, the biosurfactant for MEOR needs to be able to withstand the extreme environment of oil reservoirs with high temperature and high salinity. Halomonas meridiana BK-AB4 is a halophilic bacterium obtained from the Bledug Kuwu crater in Central Java, Indonesia. The similarity of both environment condition indicates the potential to produce… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 15 publications
0
1
0
Order By: Relevance
“…The most active isolate exhibiting the L-glutaminase production, KKU-MS11, was identified based on the 16S RNA gene as Halomonas meridiana . The potential biotechnological applications for this bacterial species were previously reported [ 22 ], while this is the first report on their ability to produce L-glutaminase. The finding of new microbial strains producing anticancer enzymes can assist with the quest for new attributes to diminish the immune reactions on account of therapy.…”
Section: Discussionmentioning
confidence: 97%
“…The most active isolate exhibiting the L-glutaminase production, KKU-MS11, was identified based on the 16S RNA gene as Halomonas meridiana . The potential biotechnological applications for this bacterial species were previously reported [ 22 ], while this is the first report on their ability to produce L-glutaminase. The finding of new microbial strains producing anticancer enzymes can assist with the quest for new attributes to diminish the immune reactions on account of therapy.…”
Section: Discussionmentioning
confidence: 97%